Panelists discuss how venous thromboembolism risk assessment and prophylaxis decisions in patients with non–small cell lung cancer require careful consideration of individual risk factors, patient ...
Concizumab is a tissue factor pathway inhibitor antagonist that enhances factor Xa production during the initiation phase of coagulation. This production improves thrombin generation and clot ...
Purpose: The implications of recent studies for guidelines that pertain to stress ulcer prophylaxis in the postoperative period are discussed. Summary: The therapeutic guidelines on stress ulcer ...
Background The use of quinolone prophylaxis in high-risk neutropenic patients is considered standard of care but the development of resistance is a concern. Previous studies have focused mainly on ...